QuidelOrtho Shares Drop on Carlyle's Secondary Offering

Dow Jones11-20
 

By Dean Seal

 

Shares of QuidelOrtho fell after the company said Carlyle Group was selling 8.26 million of its shares in an underwritten secondary offering.

The stock was down 7.3% at $35.75 in premarket trading on Wednesday. Shares had already fallen 48% year-to-date when the market closed Tuesday.

The maker of an at-home Covid-19 test and other products said after yesterday's closing bell that Carlyle Group would sell the shares in an offering set to close on Nov. 21. QuidelOrtho will not receive any proceeds from the offering.

Goldman Sachs is acting as the sole underwriter and will offer the shares to the public at a fixed price, the company said.

QuidelOrtho issued a press release on Tuesday night saying the offering had been priced, though it didn't provide the per-share price.

 

Write to Dean Seal at dean.seal@wsj.com

 

(END) Dow Jones Newswires

November 20, 2024 07:26 ET (12:26 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment